Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes ; volume:23 ; number:1 ; day:1 ; month:2 ; year:2023 ; pages:1-6 ; date:12.2023
BMC endocrine disorders ; 23, Heft 1 (1.2.2023), 1-6, 12.2023
- Classification
-
Medizin, Gesundheit
- Creator
-
Risovic, Ivona
Dumanovic, Mirjana Sumarac
Bojic, Mirjana
Djekic, Danijel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12902-023-01282-w
- URN
-
urn:nbn:de:101:1-2023042921131837203040
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Risovic, Ivona
- Dumanovic, Mirjana Sumarac
- Bojic, Mirjana
- Djekic, Danijel
- SpringerLink (Online service)
Other Objects (12)
Glucagon-like peptide 1 improved glycemic control in type 1 diabetes
Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis
A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes
Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study
Study of the serum level of fasting glucagon-like peptide-1 in type 2 diabetics and its relation to the glycemic profile
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glycemic dispersion: a new index for screening high glycemic variability
Glucagon-like peptide 1 (GLP-1)
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
Glycemic index and glycemic load of common fruit juices in Thailand
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
Glucagon-like peptide 1 improved glycemic control in type 1 diabetes
Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis
A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes
Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study
Study of the serum level of fasting glucagon-like peptide-1 in type 2 diabetics and its relation to the glycemic profile
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glycemic dispersion: a new index for screening high glycemic variability
Glucagon-like peptide 1 (GLP-1)
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
Glycemic index and glycemic load of common fruit juices in Thailand
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
Glucagon-like peptide 1 improved glycemic control in type 1 diabetes
Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis
A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes
Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study
Study of the serum level of fasting glucagon-like peptide-1 in type 2 diabetics and its relation to the glycemic profile
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glycemic dispersion: a new index for screening high glycemic variability
Glucagon-like peptide 1 (GLP-1)
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
Glycemic index and glycemic load of common fruit juices in Thailand